Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Deep brain stimulation for epilepsy.

Casey H Halpern1, Uzma Samadani, Brian Litt

  • 1Department of Neurosurgery, Center for Functional and Restorative Neurosurgery, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104, USA.

Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|January 1, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Virtual Responsive Neurostimulation Implantation: From Intracranial Connectivity to Optimized Lead Placement.

medRxiv : the preprint server for health sciences·2026
Same author

Cortical stimulation reveals effective disconnection of the epileptogenic network at seizure onset.

Epilepsia·2026
Same author

Association between Interictal Spike Rate and Seizure Frequency in a Large Epilepsy Cohort.

medRxiv : the preprint server for health sciences·2026
Same author

The seizure embedding map: A spatio-temporal transformer for comparing patients by ictal intracranial EEG features at scale.

Journal of neural engineering·2026
Same author

Regional excitability, not epileptic pathology, drives stimulation-evoked interictal spike increases.

medRxiv : the preprint server for health sciences·2026
Same author

Development of an Educational Curriculum for the Surgical Implantation of DBS Systems.

Neuromodulation : journal of the International Neuromodulation Society·2026
Same journal

Sotagliflozin improves cognitive deficits and attenuates neuroinflammation of Alzheimer's disease.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same journal

Neurological complications of current and emerging CAR-T cell therapies.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same journal

Hemodynamics Beyond Ischemic Zone Underlies Early Neurological Deterioration in Minor Stroke with Large Vessel Occlusion.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same journal

Nervonic acid and the long arc of therapeutic hope in X-linked adrenoleukodystrophy.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same journal

Long-term efficacy of subthalamic nucleus deep brain stimulation in focal motor seizures and implications for candidate selection.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same journal

Brain interstitial fluid pharmacokinetics and therapeutic effect of a BBB penetrating amyloid beta antibody measured by microdialysis.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
See all related articles

Deep brain stimulation (DBS) shows promise for treating refractory epilepsy when surgery isn't an option. Further research is needed to determine the best targets and patient selection for this epilepsy treatment.

Area of Science:

  • Neurology
  • Neurosurgery
  • Epileptology

Background:

  • Medically refractory epilepsy affects many patients unsuitable for resective surgery.
  • Deep brain stimulation (DBS) has shown success in treating movement disorders, prompting its investigation for epilepsy.
  • Existing studies suggest DBS may be effective for refractory seizures.

Purpose of the Study:

  • To explore the potential of deep brain stimulation (DBS) as a treatment for medically refractory epilepsy.
  • To review the current evidence and ongoing trials for DBS in epilepsy management.
  • To highlight the need for further research in optimizing DBS for seizure control.

Main Methods:

  • Review of open-label and small blinded trials investigating DBS for epilepsy.
  • Mention of the first randomized control trial of DBS targeting the anterior thalamic nucleus.

Related Experiment Videos

  • Discussion of the complexity of identifying optimal DBS targets due to seizure propagation pathways.

    • Main Results:

    • Promising evidence from preliminary trials suggests DBS efficacy in reducing refractory seizures.
    • The first randomized controlled trial for DBS of the anterior thalamic nucleus is ongoing.
    • Multiple potential neural targets exist, complicating definitive efficacy judgments.

    Conclusions:

    • DBS is a potential therapeutic option for patients with refractory epilepsy ineligible for surgery.
    • Further research is essential to identify optimal patient populations, targets, and stimulation parameters for DBS in epilepsy.
    • Definitive conclusions on DBS efficacy for seizure control require more extensive investigation.